Drug Database
Back to search

France· FR:61196720

HEXVIX 85 mg, poudre et solvant pour solution intravésicale

A hexaminolevulinate product containing chlorhydrate d'hexaminolévulinate, registered in France by PHOTOCURE ASA, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC V04CX06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedHEXVIX 85 mg, poudre et solvant pour …ATCV04CX06REGISTER NO.FR:61196720PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate d'hexaminolévulinateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hexaminolevulinate is registered in 11 of 19 countries.

Countries holding a registration under ATC V04CX06 (hexaminolevulinate), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search hexaminolevulinate products by name

Hexaminolevulinate · ATC V04CX06

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE D'HEXAMINOLÉVULINATE
Manufacturer
PHOTOCURE ASA
Country
France (FR)
ATC code
V04CX06
ATC class
Hexaminolevulinate
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930071700
    1 flacon(s) en verre de 10 ml - 1 seringue(s) préremplie(s) copolymère de cyclooléfines de 50 ml
    EUR 412.59

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for hexaminolevulinate.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hexaminolevulinate against other medicinesHow interaction checks work

Hexaminolevulinate · interactions on record

1 record

  • 1 severe

Most severe, free to view

  • ValrubicinL01DB09severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hexaminolevulinate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hexaminolevulinate products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Hexvix
  • Belgium · Hexvix
  • Czechia · Hexvix
  • Germany · Hexvix
  • Denmark · Hexvix
  • Estonia · Hexvix
  • Spain · Hexvix
  • Finland · Hexvix
  • United Kingdom (Northern Ireland) · Hexvix
  • Greece · Hexvix
  • Hungary · Hexvix
  • Ireland · Hexvix
  • Iceland · Hexvix
  • Italy · Hexvix
  • Lithuania · Hexvix
  • Latvia · Hexvix
  • Netherlands · Hexvix
  • Norway · Hexvix
  • Poland · Hexvix
  • Portugal · Hexvix
  • Sweden · Hexvix
  • Slovenia · Hexvix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1893c067-39fe-4a9b-ad82-74c0255cac69
GET /v1/drugs/1893c067-39fe-4a9b-ad82-74c0255cac69?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61196720",
  "date_amm": "2005-08-12",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "CHLORHYDRATE D'HEXAMINOLÉVULINATE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution",
  "voies_administration": "intravésicale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about hexaminolevulinate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console